MedTrace Logo

Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression

NCT02624102 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2022-04-04

No results posted yet for this study

Summary

Major Depressive Disorder (MDD) is a mood disorder, highly prevalent in Brazil and in world. The treatments of choice are the psychotropic drugs of the class of antidepressants and Behavioral or Cognitive Behavior Therapy (CBT). The aim of this study is to compare the efficacy of Trial Based Cognitive Therapy with the Behavioral Activation and pharmacotherapy in the treatment of MDD in a randomized clinical trial witch 96 patients with MDD,

Conditions

Interventions

BEHAVIORAL

Trial based cognitive therapy

Patients with MDD, in use of antidepressants plus Trial Based Cognitive Therapy

BEHAVIORAL

Behavioral Activation

Patients with MDD, in use of antidepressants plus Behavioral Activation

DRUG

Antidepressants

Patients with MDD, in use of antidepressants (fluoxetine, citalopram, escitalopram, bupropion, etc.) without psychotherapy.

Sponsors & Collaborators

  • Federal University of Bahia

    collaborator OTHER

  • Hemanny, Curt, M.D.

    lead INDIV

Principal Investigators

  • Irismar Reis de Oliveira, Ph.D · Federal University of Bahia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-12-31
Completion
2019-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02624102 on ClinicalTrials.gov